Discuss research goals, sample availability, and sequencing requirements
Submit tumor and matched normal samples with clinical metadata under IRB protocol
PeptideXme pipeline processes samples through all 5 stages
Receive interactive web report and PDF with neoantigen candidates and recommendations
| Type | Requirement |
|---|---|
| Tissue | FFPE or fresh-frozen tumor tissue, ≥1mm³ volume, ≥5 slides |
| Blood (normal) | Matched normal blood, 8.5 mL in Streck tube |
| Optional: scRNA-seq | Viable single-cell suspension, ≥10,000 cells |
| Optional: TCR-seq | Blood or tumor infiltrating lymphocytes |
All samples processed under IRB-approved protocols. PeptideXme is a Research Use Only (RUO) platform. No clinical diagnostic claims are made.